Health Care & Life Sciences » Pharmaceuticals | Instituto Rosenbusch

Instituto Rosenbusch S.A. | Balance Sheet

Fiscal year is January-December. All values ARS Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,308.00
5,076.00
7,545.10
6,171.90
5,353.10
14,932.10
Total Accounts Receivable
45,308.70
49,087.60
70,669.60
84,047.20
99,951.80
136,628.70
Inventories
51,513.30
58,402.30
59,095.20
72,025.70
76,915.10
133,678.10
Other Current Assets
-
2,179.00
1,484.00
3,350.50
108.70
362.60
Total Current Assets
99,130.00
114,744.80
138,793.90
165,595.20
182,328.70
285,601.50
Net Property, Plant & Equipment
19,426.40
18,450.20
27,092.70
32,028.80
31,028.80
79,410.10
Total Investments and Advances
7,201.40
7,467.10
250.20
231.90
166.40
1,742.70
Intangible Assets
131.20
93.20
33.50
1.00
0.60
1.40
Total Assets
125,889.00
140,755.30
166,170.30
197,856.80
213,524.60
366,755.70
ST Debt & Current Portion LT Debt
10,060.10
9,552.50
22,882.70
29,011.50
36,155.00
Accounts Payable
26,165.70
24,663.60
27,201.50
35,641.50
36,181.50
Income Tax Payable
1,926.70
1,610.10
657.60
217.80
327.20
Other Current Liabilities
12,039.60
21,021.20
25,185.70
33,732.10
38,476.70
Total Current Liabilities
50,192.10
56,847.30
75,927.50
98,602.90
111,140.40
Long-Term Debt
13,278.30
10,815.60
11,238.50
3,650.40
6,677.40
Provision for Risks & Charges
1,905.20
1,754.50
1,174.30
2,424.00
2,988.10
Deferred Taxes
708.60
708.60
825.00
825.00
825.00
Other Liabilities
2,154.10
2,384.70
6,384.70
9,118.50
5,316.30
Total Liabilities
68,238.30
72,510.70
95,549.90
114,620.90
126,947.10
Common Equity (Total)
54,818.90
64,021.80
64,631.80
75,752.20
77,109.20
Total Shareholders' Equity
54,818.90
64,021.80
64,631.80
75,752.20
77,109.20
Total Equity
57,650.70
68,244.60
70,620.40
83,235.90
86,577.40
Liabilities & Shareholders' Equity
125,889.00
140,755.30
166,170.30
197,856.80
213,524.60
Accumulated Minority Interest
2,831.80
4,222.80
5,988.60
7,483.70
9,468.30

About Instituto Rosenbusch

View Profile
Address
HipĆ³lito Yrigoyen 1628
Buenos Aires Buenos Aires 1089
Argentina
Employees -
Website http://www.rosenbusch.com
Updated 07/08/2019
Instituto Rosenbusch SA engages in the manufacture and marketing of veterinary products. It operates through the following business segments: Biological Products, Pharmaceutical Products, and Others. The Biological Products segment includes products for reproductive-respiratory complex, brucellosis and carbuncle, clostridial and other vaccines, horses, pneumonia and calve diarrhea, and queratoconjuntivitis.